| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,439 |
4,167 |
$134K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,609 |
2,490 |
$101K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,534 |
4,406 |
$85K |
| 92567 |
|
6,247 |
5,894 |
$77K |
| 92552 |
|
3,370 |
3,263 |
$47K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,453 |
1,444 |
$45K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,089 |
1,084 |
$33K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
897 |
891 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
662 |
653 |
$18K |
| 69210 |
|
358 |
350 |
$15K |
| 92081 |
|
2,396 |
2,389 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,632 |
2,606 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
463 |
459 |
$10K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
233 |
231 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
4,543 |
4,455 |
$7K |
| 86580 |
|
663 |
654 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
822 |
822 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,088 |
1,047 |
$3K |
| 81002 |
|
1,712 |
1,663 |
$2K |
| 96127 |
|
872 |
871 |
$2K |
| 87070 |
|
965 |
926 |
$1K |
| 87110 |
|
214 |
213 |
$1K |
| 83655 |
|
430 |
422 |
$902.32 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
162 |
161 |
$788.28 |
| 81000 |
|
1,259 |
1,202 |
$460.59 |
| 90658 |
|
1,025 |
1,012 |
$308.13 |
| 99381 |
|
12 |
12 |
$247.37 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$242.40 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
248 |
243 |
$210.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
278 |
276 |
$125.79 |
| 90734 |
|
186 |
185 |
$92.98 |
| 81001 |
|
556 |
553 |
$78.56 |
| 36410 |
|
475 |
454 |
$44.34 |
| 90655 |
|
13 |
13 |
$43.04 |
| 90680 |
|
100 |
99 |
$35.00 |
| 90698 |
|
28 |
28 |
$0.00 |
| 90686 |
|
19 |
19 |
$0.00 |
| 90620 |
|
58 |
58 |
$0.00 |
| 90744 |
|
24 |
24 |
$0.00 |
| 90716 |
|
24 |
24 |
$0.00 |
| 90697 |
|
14 |
14 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90649 |
|
324 |
323 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
28 |
$0.00 |
| 90671 |
|
76 |
76 |
$0.00 |
| 90670 |
|
295 |
294 |
$0.00 |
| 90633 |
|
287 |
287 |
$0.00 |
| 90707 |
|
13 |
13 |
$0.00 |
| 3725F |
|
282 |
282 |
$0.00 |
| 90715 |
|
60 |
57 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
29 |
$0.00 |
| 90461 |
|
24 |
24 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
30 |
29 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$0.00 |
| 90710 |
|
47 |
47 |
$0.00 |